Analyst Target Downside
Analyst Downside Risks – Page 11
Stocks where analyst target estimates imply downside from the current market price.
Showing 241–256 of 256 stocks
Page 11 of 11
Data as of
Nov 6, 2026
Criteria
A positive analyst price target and negative target gap are required; $100M+ market cap applies by default.
Ranking
Major U.S. listings and broader analyst coverage first, then bounded analyst-implied downside.
Data quality
Validated results require usable primary evidence and apply sector-appropriate quality checks; unavailable supporting metrics remain neutral rather than becoming zero.
Strong favorable
Favorable
Watch
Risk / negative
Neutral
↔ Scroll horizontally to compare all relevant metrics Swipe horizontally to compare all relevant metrics
Rank
Ticker
Market
Analyst Upside
Buy Consensus
Coverage
Fair Value Gap
P/E
Health
Market Cap
#241
OPRT
NASDAQ
-0.9% Downside
50.0% Buy
Buy
4
ratings
2.1% Upside
Fair
14.4x
Great
$534.50M
#242
FMS
NYSE
-0.8% Downside
0.0% Buy
Mixed
4
ratings
28.3% Upside
Undervalued
13.3x
Good
$12.33B
#243
LIVN
NASDAQ
-0.7% Downside
75.0% Buy
Strong Buy
8
ratings
-5.8% Downside
Fair
25.6x
Great
$5.02B
#244
BHP
NYSE
-0.6% Downside
33.3% Buy
Mixed
6
ratings
-11.1% Downside
Fair
20.4x
Good
$208.00B
#245
PAG
NYSE
-0.6% Downside
12.5% Buy
Mixed
8
ratings
-17.6% Downside
Fair
15.4x
Fair
$13.93B
#246
FTDR
NASDAQ
-0.6% Downside
57.1% Buy
Buy
7
ratings
-18.2% Downside
Overvalued
24.1x
Great
$6.61B
#247
MTH
NYSE
-0.6% Downside
25.0% Buy
Mixed
8
ratings
-8.6% Downside
Fair
15.4x
Good
$4.58B
#248
CINF
NASDAQ
-0.5% Downside
25.0% Buy
Mixed
8
ratings
9.7% Upside
Fair
10.9x
Great
$28.91B
#249
MORN
NASDAQ
-0.5% Downside
66.7% Buy
Buy
3
ratings
20.8% Upside
Undervalued
20.6x
Great
$9.17B
#250
CON
NYSE
-0.4% Downside
100.0% Buy
Strong Buy
9
ratings
-20.4% Downside
Overvalued
27.6x
Great
$5.38B
#251
FULC
NASDAQ
-0.4% Downside
0.0% Buy
Mixed
4
ratings
32.0% Upside
Undervalued
—
Fair
$280.80M
#252
VIA
NYSE
-0.2% Downside
100.0% Buy
Strong Buy
6
ratings
-19.1% Downside
Overvalued
—
Fair
$3.08B
#253
OCSL
NASDAQ
-0.2% Downside
0.0% Buy
Mixed
7
ratings
—
—
Fair
$1.10B
#254
DASTY
OTC
-7.4% Downside
33.3% Buy
Mixed
3
ratings
20.1% Upside
Undervalued
25.5x
Good
$38.91B
#255
SMMNY
OTC
-3.5% Downside
66.7% Buy
Buy
3
ratings
20.2% Upside
Undervalued
22.6x
Great
$56.21B
#256
FNMA
OTC
-3.2% Downside
0.0% Buy
Mixed
4
ratings
-1.9% Downside
Fair
22.0x
Good
$24.45B
No company or ticker on this page matches your search.